COR

Cencora Inc.

COR.US cencora.com + Research + Basket
CIK 0001140859
Employees 47,000
Phone 610 727 7000
Fiscal year end September
IPO Apr 04, 1995
Address 1 West First Avenue, Conshohocken, PA, United States, 19428-1800
330.84
+0.31 (+0.09%)
USD · NYSE
52-week range
243.78
375.33
Trading at 66% of the 52-week range
Market Cap
63.07B
P/E Ratio
24.54
Forward P/E
16.29
Book Value
15.99
Div. Yield
0.72%
% Institutions
99.27%
% Insiders
4.30%

1 Year

-2.3%

3 Year

+83.2%

10 Year

+443.9%
Description

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Actions

Add an action for COR.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Robert P. Mauch Ph.D., PharmD President, CEO & Director 1967
Ms. Elizabeth S. Campbell J.D. Executive VP & Chief Legal Officer 1975
Mr. James F. Cleary Jr. Advisor 1963
Ms. Silvana Battaglia Advisor 1968
Ms. Eva C. Boratto Executive VP & CFO 1967
Mr. Lazarus Krikorian Senior VP, Chief Accounting Officer & Corporate Controller 1965
Mr. Pawan Singh Verma Executive VP and Chief Data & Information Officer 1977
Mr. Bennett S. Murphy Senior VP Of Investor Relations & Enterprise Productivity and Treasury NA
Ms. Samantha L. Hammock Executive VP & Chief Human Resources Officer 1979
Mr. Richard Tremonte EVP and President of U.S. Pharmaceuticals & Animal Health NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 30, 2026 Ro Khanna N/A Sale N/A $309.84 N/A —
Mar 23, 2026 Ro Khanna N/A Sale N/A $320.68 N/A —
Jan 29, 2026 Ro Khanna N/A Purchase N/A $351.49 N/A —
Jan 20, 2026 Robert P Mauch N/A Sale 5.10K $354.73 $1.81M SEC
Dec 19, 2025 Elizabeth S Campbell N/A Sale 3.35K $342.10 $1.15M SEC
Dec 19, 2025 Silvana Battaglia N/A Sale 1.68K $345.00 $578.57K SEC
Dec 18, 2025 Robert P Mauch N/A Sale 5.10K $343.45 $1.75M SEC
Nov 18, 2025 Robert P Mauch N/A Sale 5.10K $366.64 $1.87M SEC
Oct 27, 2025 Michael T. McCaul N/A Sale N/A $336.00 N/A —
Oct 20, 2025 Robert P Mauch N/A Sale 5.10K $326.80 $1.67M SEC
Sep 18, 2025 Robert P Mauch N/A Sale 5.10K $290.00 $1.48M SEC
Sep 16, 2025 Steven H Collis N/A Sale 31.35K $289.86 $9.09M SEC
Aug 22, 2025 Michael T. McCaul N/A Sale N/A $292.25 N/A —
Aug 07, 2025 Michael T. McCaul N/A Sale N/A $278.18 N/A —
Jul 22, 2025 Steven H Collis N/A Sale 14.58K $292.67 $4.27M SEC
Jul 18, 2025 Robert P Mauch N/A Sale 4.97K $294.11 $1.46M SEC
Jun 27, 2025 Michael T. McCaul N/A Sale N/A $299.71 N/A —
Jun 24, 2025 Steven H Collis N/A Sale 14.58K $292.62 $4.27M SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 18.21M Jun 30, 2026 9.54% $0.08 -8.67%
Vanguard Capital Management, LLC 12.38M Jun 30, 2026 6.49% $0.07 0.53%
Vanguard Portfolio Management, LLC 9.61M Jun 30, 2026 5.04% $0.12 0.22%
State Street Corp 9.27M Jun 30, 2026 4.86% $0.08 0.91%
T. Rowe Price Investment Management,Inc. 7.41M Jun 30, 2026 3.88% $1.37 17.74%
T. Rowe Price Associates, Inc. 7.13M Jun 30, 2026 3.74% $0.20 -2.61%
JPMorgan Chase & Co 5.94M Jun 30, 2026 3.11% $0.09 21.66%
Geode Capital Management, LLC 5.45M Jun 30, 2026 2.86% $0.08 -2.00%
Boston Partners Global Investors, Inc 4.87M Jun 30, 2026 2.55% $1.23 8.61%
Wellington Management Company LLP 4.56M Jun 30, 2026 2.39% $0.22 0.25%
FMR Inc 4.12M Jun 30, 2026 2.16% $0.05 -38.35%
Morgan Stanley - Brokerage Accounts 4.09M Jun 30, 2026 2.14% $0.06 -9.83%
Bank of America Corp 3.73M Jun 30, 2026 1.96% $0.07 -9.77%
NORGES BANK 2.47M Jun 30, 2026 1.30% $0.07 1.58%
The Goldman Sachs Group Inc 2.27M Jun 30, 2026 1.19% $0.06 2.77%
Amundi 2.23M Jun 30, 2026 1.17% $0.15 43.53%
Northern Trust Corp 2.16M Jun 30, 2026 1.13% $0.07 -1.09%
Amvescap Plc. 2.02M Jun 30, 2026 1.06% $0.05 -49.31%
Capital Research Global Investors 1.98M Jun 30, 2026 1.04% $0.08 1.04%
Carmignac Gestion 1.75M Jun 30, 2026 0.92% $6.42 58.67%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 5.75M 3.01% ▼ 2.06% Sep 30, 2026
2 Vanguard 500 Index Investor 5.01M 2.63% ▼ 3.08% Sep 30, 2026
3 T. Rowe Price Capital Appreciation 3.90M 2.04% ▼ 16.81% Sep 30, 2026
4 Vanguard MStar Mid Cap Index Instl 3.88M 2.03% ▼ 2.90% Sep 30, 2026
5 Vanguard Health Care Inv 2.84M 1.49% ▲ 20.19% Jun 30, 2026
6 iShares Core S&P 500 ETF 2.54M 1.33% ▼ 0.16% Sep 30, 2026
7 Fidelity 500 Index 2.53M 1.32% ▲ 0.39% Aug 31, 2026
8 State Street® SPDR® S&P 500® ETF 2.34M 1.23% ▲ 0.00% Sep 30, 2026
9 Vanguard MStar Value Index Investor 1.73M 0.91% ▼ 2.19% Sep 30, 2026
10 State Street®HlthCrSelSectSPDR®ETF 1.35M 0.71% ▲ 0.31% Sep 30, 2026

Financial Highlights

▼
Market Cap: $63.07B
EBITDA: $5.55B
P/E Ratio: $24.54
PEG Ratio: $0.68
Book Value: $15.99
Dividend/Share: $2.35
Dividend Yield: 0.72%
Earnings/Share: $13.47
Profit Margin: 0.79%
Operating Margin: 1.41%
ROA (TTM): 3.56%
ROE (TTM): 96.87%
Revenue (TTM): $332.77B
Revenue/Share (TTM): $1.72K
Earnings Growth (YOY): 11.90%
Revenue Growth (YOY): 5.10%

Valuation Metrics

Enterprise Value: $70.80B
Trailing P/E: 24.54
Forward P/E: 16.29

Shares Statistics

Shares Outstanding: 190.83M
Shares Float: 180.25M
% Insiders: 4.30%
% Institutions: 99.27%
Shares Short: 3.93M
Shares Short (Prior Month): 4.31M
Short Ratio: 3.16
Short % Float: 2.35%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$321.33B
Cost of Goods Sold
adjust
$-311.19B
Gross Profit
subtotal
$10.14B
SG&A
adjust
$-6.49B
Operating Income
subtotal
$3.65B
Other / Non-Operating Items
adjust
$-2.09B
Net Income
subtotal
$1.55B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about COR.US!